All In Biotech

Drug Trial Radar · NCT06757712

Periodization Resistance Training on Quality of Life in Females With Hypothyroidism

Nonlinear Versus Linear Periodized Resistance Training on Quality of Life in Females With Hypothyroidism

Last checked: Nov 20, 2026Latest source record: Sep 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Jan 1, 2025

Primary completion

Oct 1, 2025

Study completion Oct 15, 2025

Sponsor

Lead sponsor
Cairo UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 35 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be conducted to compare between the effect of nonlinear and linear periodized training on quality of life in females with hypothyroidism.

Conditions

  • Hypothyroidism

Interventions

  • non linear periodization exerciseOther

    The non-linear periodized resistance training program follows a 12-week schedule with varying intensity levels across three training days per week. The intensity fluctuates between very light (VL), light (L), moderate (M), heavy (H), and very heavy (VH) workouts, distributed strategically throughout the week. Each training day implements different intensity levels, and an active rest day follows any workout session.

  • linear periodization exerciseOther

    The linear periodization exercise program spans 12 weeks with systematically varied training parameters. During weeks 1-2, participants perform 3 sets of 10 repetitions, followed by 3 sets of 8 repetitions in weeks 3-4. The program progresses to 4 sets of 6 repetitions in weeks 5-6, then 3 sets of 6 repetitions during weeks 7-8. The final phases consist of 4 sets of 4 repetitions in weeks 9-10, concluding with 3 sets of 4 repetitions in weeks 11-12. Training loads advance through autoregulatory progression, where participants progress at their individual pace under supervision. While sets and repetitions remain fixed within each phase, load progression is determined by performance in the final set of each exercise, ensuring safe and effective advancement.

  • medical treatmentDrug

    The medical treatment will be received for 12 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serum thyroid stimulating hormone (TSH) levelTime frame: 12 weeks
  2. FreeT4 (thyroxine) levelTime frame: 12 weeks
  3. Health related Quality of life questionnaireTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Suez University

    Suez, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.